Sol-Gel Technologies (SLGL) Research & Development (2017 - 2026)

Sol-Gel Technologies (SLGL) reported Research & Development of $2.8 million for Q1 2026, down 68.49% year-over-year from $8.8 million in Q1 2025, and down 22.27% quarter-over-quarter from $3.6 million in Q4 2025.

Sol-Gel Technologies (SLGL) Research & Development (2017 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 10 years of Research & Development data on file, last reported at $2.8 million in Q1 2026.

  • Research & Development for Q1 2026 came in at $2.8 million, down 68.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $16.7 million (down 21.38% YoY), and the FY2025 annual result was $22.8 million, up 28.09% from the prior year.
  • Research & Development slipped to $2.8 million in Q1 2026 per SLGL's latest filing, from $3.6 million in the prior quarter.
  • Over five years, Research & Development peaked at $9.4 million in Q1 2023 and troughed at $2.0 million in Q3 2022.
  • A 5-year average of $4.7 million and a median of $4.6 million in 2025 frame the typical range for Research & Development.
  • The sharpest annual moves came in 2023 and 2026: Research & Development surged 132.21% in 2023, then plunged 68.49% in 2026.
  • A 5-year view of Research & Development shows it stood at $4.2 million in 2022, then slipped by 1.09% to $4.2 million in 2023, then gained by 24.6% to $5.2 million in 2024, then plunged by 31.04% to $3.6 million in 2025, then retreated by 22.27% to $2.8 million in 2026.
  • Business Quant data shows SLGL's Research & Development at $2.8 million in Q1 2026, $3.6 million in Q4 2025, and $5.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 2.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.79 Mn
Dec 31, 2025 3.58 Mn
Sep 30, 2025 5.73 Mn
Jun 30, 2025 4.65 Mn
Mar 31, 2025 8.84 Mn
Dec 31, 2024 5.20 Mn
Sep 30, 2024 4.82 Mn
Jun 30, 2024 2.44 Mn
Mar 31, 2024 5.35 Mn
Dec 31, 2023 4.17 Mn
Sep 30, 2023 4.67 Mn
Jun 30, 2023 5.31 Mn
Mar 31, 2023 9.39 Mn
Dec 31, 2022 4.22 Mn
Sep 30, 2022 2.04 Mn
Jun 30, 2022 2.38 Mn
Mar 31, 2022 4.04 Mn
Dec 31, 2021 4.99 Mn
Sep 30, 2021 5.99 Mn
Jun 30, 2021 6.93 Mn